Regeneron gout drug works in one trial, fails other - Reuters

Regeneron gout drug works in one trial, fails other Reuters The company is developing Arcalyst for preventing or treating gout flares in patients who received uric acid-lowering therapy. The therapy often triggers a ... Regeneron's Billion Research Push Mimics GenentechBusinessWeek ARCALYST(R) (rilonacept) Meets Primary and All Secondary Endpoints in Phase 3 ...MarketWatch (press release) all 74 news articles »

Nuon Therapeutics Announces Results of Studies Confirming the Uric Acid ... - MarketWatch (press release)

Nuon Therapeutics Announces Results of Studies Confirming the Uric Acid ... MarketWatch (press release) ... in which uric acid crystals trigger an immune response in the body and produce painful and debilitating inflammation. Gout patients also have a chronic, ... and more »

Study shows Novartis' ACZ885 prevents acute flares in gout patients - pharmabiz.com

Study shows Novartis' ACZ885 prevents acute flares in gout patients pharmabiz.com It is caused by the accumulation in joints and surrounding tissues of uric acid crystals that trigger the overproduction of interleukin-1ß (IL-1ß). ... and more »

Dr. Day Focus: Be Aware of What Flares Arthritis - Washington Informer

Dr. Day Focus: Be Aware of What Flares Arthritis Washington Informer Studies show that changes in temperature or barometric pressure can trigger joint pain, although researchers have not confirmed exactly how that happens. ...